Showing results (1-10 of 639) with videos related to
Sort By:
Pageof 64
Cancer|May 15, 1987
Splenectomy for end-stage chronic lymphocytic leukemiaR S Stein, D Weikert, V Reynolds, et al.Leukemia & Lymphoma|September 1, 1996
Etoposide and mitoxantrone as a second cycle of consolidation therapy following high dose cytosine arabinoside and daunorubicin in patients with acute non-lymphocytic leukemia in remission: a pilot studyR S Stein, J P Greer, J M Flexner, et al.The American Journal of the Medical Sciences|December 1, 1994
Treatment of aplastic anemia with an investigational antilymphocyte serum prepared in rabbitsR S Stein, R T Means, S B Krantz, et al.Southern Medical Journal|July 1, 1986
Clinical experience with amphotericin B in acute myelogenous leukemiaR S Stein, J P Greer, W Ferrin, et al.Southern Medical Journal|December 1, 1984
Idiopathic thrombocytopenic purpura during remission of thrombotic thrombocytopenic purpuraR S Stein, J M FlexnerSouthern Medical Journal|March 1, 1980
Chronic myelogenous leukemia: a 22-year survivalR S Stein, J M FlexnerCancer Treatment Reports|June 1, 1986
Modified cyclophosphamide, vincristine, methotrexate, leucovorin, and cytarabine (COMLA) in intermediate- and high-grade lymphoma: an effective short-course regimenM R Baer, R S Stein, J P Greer, et al.Cancer|August 1, 1978
Anatomical substages of stage III Hodgkin's disease: implications for staging, therapy, and experimental designR S Stein, R M Hilborn, J M Flexner, et al.Cancer|December 1, 1982
Clinical value of empirical amphotericin B in patients with acute myelogenous leukemiaR S Stein, J Kayser, J M FlexnerHematological Oncology|September 1, 1989
Malignant lymphomas of follicular centre cell origin in man. VII. Prognostic features in small cleaved cell lymphomaR S Stein, J P Greer, J B Cousar, et al.Pageof 64